3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP | 1 |
de Herder, WW; Hofland, LJ; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Nobels, FR; Oei, HY; Reijs, AE | 1 |
de Herder, WW; de Swart, J; Kaandorp, Y; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Reijs, AE | 1 |
3 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.
Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
Topics: Adenoma; Adolescent; Adult; Aminoquinolines; Benzamides; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1996 |
Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
Topics: Adenoma; Benzamides; Brain; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1999 |